Sesquiterpene derivatives

Details Sesquiterpene derivatives Sesquiterpene derivatives

1999-09-20

2000-11-07

Stockton, Laura L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Silicon containing doai

514382, 514410, 548251, 548406, 548417, 548418, A61K 31407, C07D491052, C07D491153

Patent

active

061437328

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD

The present invention relates to novel compounds having antiviral activities. In more detail, the invention relates to sesquiterpene derivatives having inhibitory activities against influenza A and B, and pharmaceutical compositions containing such derivatives.


BACKGROUND ART

There have been no established method for treating the commonest viral disease, influenza. Human influenza viruses are classified into types A, B and C, depending on their internal antigens, among which types A and B are known to cause intensive symptoms. Amantadine has been known for more than 20 years as a chemotherapeutic agent, though efficacy thereof has not been evaluated yet. Accordingly, there has been a strong demand for the development of novel and effective anti-influenza agents.
It has been known that microorganisms can produce various useful compounds. For example, Stachybotrys, a fungus is known to produce compounds having pyran fused ring [(1) Japanese Patent Publication (KOKAI) 176782/1993; (2) Japanese Patent Publication (KOKAI) 128266/1994; (3) Japanese Patent Publication (KOKAI) 239869/1994; (4) Japanese Patent Publication (KOKAI) 256350 1994; (5) J. Org. Chem. 57 6700-03 (1992)]. These references, however, merely describe that such compounds have nerve growth factor (NGF) activating effects and are useful for the treatment of Alzheimer's diesease (References 1-4) or that such compounds have antibacterial and antifungal effects (Reference 5). Thus, it has not been known that Stachybotrys produces compounds having antiviral activities.
Further, the following references describe compounds having spiro-type fused ring of tetrahydrofuran ring [(6) Japanese Patent Publication (KOKOKU) 11634/1982 (U.S. Pat. No. 4,229,466); (7) Japanese Patent Publication (KOKOKU) 32170/1987 (U.S. Pat. No. 4,831,053); (8) Japanese Patent Publication (KOKAI) 145161/1995; (9) WO 95/26344]. Among these references, References (6), (7) and (9) merely show that their compounds are useful for the treatment of nephritis, hepatitis, and depression/mania, and the like, and Reference (8) merely shows that the compounds have retrovirus protease inhibitory effects.
Further, it is described that terpenehydroquinone derivatives isolated from poriferan have antiviral effects (WO 91/12250), but which does not disclose the compounds of the present invention.
In addition, natural-type sesquiterpene derivatives producible from strains belonging to the Stachybotrys genus and the synthetic derivatives are described in the PCT application (PCT/JP96/02749, filing date: Sep. 25, 1996, applicant: Shionogi), but which does not describe the compounds of the present invention.
Therefore, the development of novel and effective antiviral agents, in particular, those effective against influenza virus has long been demanded.


DISCLOSURE OF THE INVENTION

The present inventors have found that, when cultivated in an appropriate medium, some strains belonging to the Stachybotrys genus produce a substance (SQ-02-S5 et al.) having a strong inhibitory activity against virus. Further at this opportunity, they have synthesized novel sesquiterpene derivatives through the chemical modification of such natural products and found that those derivatives have remarkable activity against virus, in particular, influenza A and B viruses.
Thus, the present invention provides a compound of the formula: ##STR2## wherein R.sup.1 is hydrogen or halogen; and R.sup.2 is hydrogen, halogen, azido, an optionally substituted lower alkyl, an optionally substituted lower alkylcarbonyl, an optionally substituted arylcarbonyl, an optionally substituted heteroarylcarbonyl, --OR.sup.7 (wherein R.sup.7 is hydrogen, an optionally substituted lower alkyl, an optionally substituted lower alkylcarbonyl, an optionally substituted arylcarbonyl, an optionally substituted heteroarylcarbonyl, an optionally substituted lower alkylsulfonyl, an optionally substituted arylsulfonyl, an optionally substituted heteroarylsulfony, --SO.sub.3 H, an optionally substituted aryl, an optionally substituted a

Affiliated with

Also associated with

Rating

Sesquiterpene derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sesquiterpene derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sesquiterpene derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1641213